drug companies

(Newser) - The Times tackles the growing use of antipsychotic drugs in children, contentious because the drugs are risky and have no approved use for minors. But the trend is also questionable because it coincides with increasing payments to psychiatrists by the companies that market the drugs. In Minnesota, these payments rose...

(Newser) - The Food and Drug Administration would be given sweeping new powers to order drug recalls, regulate advertising and mandate changes in labels under a bill passed by the Senate yesterday. The bill signals a fundamental shift in the FDA's role, the New York Times reports, requiring the agency to track...

(Newser) - Doctors are paid millions of dollars by drug companies to give their patients anemia medicine which regulators now say may be dangerous. Spurred by competiton between several similar drugs, companies reward doctors with rebates, which allow them to make a significant profit, the New York Times reports.